Skip to main content
. 2014 May 12;18(3):R97. doi: 10.1186/cc13868

Table 3.

Treatment and vasopressor use characteristics

Treatment Number Percentage
Steroids
1,893
21.8
Activated protein C
292
3.4
Source control required
2,564
39.4
Pressor/inotrope agents used in first 24 hours
 Norepinephrine
4,376
67.2
 Dopamine
3,502
53.8
 Phenylephrine
1,466
22.5
 Dobutamine
793
12.2
 Vasopressin
708
10.7
 Epinephrine 313 4.8